ReviewDiagnostics (Basel, Switzerland)2021

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets.

Daniela Maria Tanase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.